查詢結果分析
相關文獻
- 子宮頸癌中拓樸酵素I活性的升高與喜樹鹼增強放射治療的展現
- Implications of a Failed Prospective Trial of Adjuvant Therapy after Radical Hysterectomy for Stage Ib-IIa Cervical Carcinoma with Pelvic Node Metastases
- Results of Postoperative Radiotherapy for Clinical Stage Ib Uterine Cervical Carcinoma with Evidence of Microscopic Involvement of Surgical Margin, Parametrium and/or Lymph Node Metastasis
- 子宮頸癌之術後放射治療
- A Phase Ⅱ Trial of Concurrent Chemoradiation with Weekly Cisplatin and Glutathione for Bulky Advanced Cervical Cancer
- 子宮頸癌的預後因素及化學治療在子宮頸癌治療的角色
- 非外科治療晚期子宮頸癌
- 一位子宮頸癌病患之護理經驗
- Prophylactic Para-Aortic Radiotherapy and Concomitant Chemotherapy for Patients with Cervical Carcinoma: Preliminary Analysis of Outcome and Toxicity
- 子宮頸癌放射治療的結果及直腸後遺症的分析(新光醫院的五年經驗)
頁籤選單縮合
題名 | 子宮頸癌中拓樸酵素I活性的升高與喜樹鹼增強放射治療的展現=Elevated Topoisomerase I Activity in Cervical Cancer as a Target for Potentiation of Radiotherapy |
---|---|
作者 | 余慕賢; 羅傅倫; | 書刊名 | 中華民國婦癌醫學雜誌 |
卷期 | 2001:1 2001.04[民90.04] |
頁次 | 頁1-15 |
分類號 | 417.2832 |
關鍵詞 | 喜樹鹼; 拓樸酵素I; 子宮頸癌; 放射治療; Camptothecin; Topoisomerase I; Cervical carcinoma; Radiotherapy; |
語文 | 中文(Chinese) |